Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending June 11, 2007. The report details a specific corporate action regarding the repurchase of the company's own shares, authorized by shareholders at the Annual General Meeting held on May 23, 2007.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share capital movements.
- Shares Repurchased: 1,500,000 Ordinary shares of 25 pence each.
- Repurchase Price: 1,310.12 pence per share.
- Treasury Shares Held: 312,239,158 shares (representing 5.47% of total voting rights).
- Shares in Issue: 5,708,424,753 shares (excluding Treasury shares).
Material Changes
The primary material change reported is the increase in the company's Treasury share holdings following the June 11, 2007 transaction. The total number of shares held in Treasury now represents 5.47% of the total voting rights in the Company.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, risks, or contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities and is made in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Investor Verification Points
- Verify the total number of shares in issue (5,708,424,753) for calculating disclosure thresholds under Financial Services Authority rules.
- Confirm the updated Treasury share count (312,239,158) and its percentage of voting rights (5.47%).
- Note that this filing does not contain financial performance data; refer to Form 20-F for comprehensive financial results.